KPX Lifescience Co Ltd
KOSDAQ:114450
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
KPX Lifescience Co Ltd
Net Income (Common)
KPX Lifescience Co Ltd
Net Income (Common) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
K
|
KPX Lifescience Co Ltd
KOSDAQ:114450
|
Net Income (Common)
₩110.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-32%
|
|
|
Samsung Biologics Co Ltd
KRX:207940
|
Net Income (Common)
₩1.8T
|
CAGR 3-Years
31%
|
CAGR 5-Years
49%
|
CAGR 10-Years
N/A
|
|
|
A
|
ADM Korea Inc
KOSDAQ:187660
|
Net Income (Common)
-₩14.8B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
P
|
Peptron Inc
KOSDAQ:087010
|
Net Income (Common)
-₩13.8B
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
-18%
|
|
|
S
|
ST Pharm Co Ltd
KOSDAQ:237690
|
Net Income (Common)
₩55B
|
CAGR 3-Years
45%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
8%
|
|
|
L
|
LegoChem Biosciences Inc
KOSDAQ:141080
|
Net Income (Common)
-₩74.3B
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-60%
|
CAGR 10-Years
-25%
|
|
KPX Lifescience Co Ltd
Glance View
KPX LIFESCIENCE Co., Ltd. engages in the production and sale of pharmaceutical and agricultural raw materials and intermediates. The company is headquartered in Yeosu, Jeollanam-Do and currently employs 61 full-time employees. The company went IPO on 2009-12-22. The Company’s products consist of AMZ and CCIM, which are used as crop protection materials; EDP-CL, which is a antibiotic used as ingredient of piperacillin; PM06, which is used for treatment of allergic diseases, and DSIC, which is used as pharmaceutical intermediate. The firm also provides antibiotics and others. The firm distributes its products within domestic market and to overseas markets, including Japan, the United States, Europe and others.
See Also
What is KPX Lifescience Co Ltd's Net Income (Common)?
Net Income (Common)
110.1m
KRW
Based on the financial report for Dec 31, 2025, KPX Lifescience Co Ltd's Net Income (Common) amounts to 110.1m KRW.
What is KPX Lifescience Co Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
-32%
Over the last year, the Net Income (Common) growth was -93%.
